Citations (121)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (22)
Thomas Müller, Carolin Tasser, Michael Tesar, Ivica Fucek, Ute Schniegler-Mattox, Joachim Koch & Kristina Ellwanger. (2023) Selection of bispecific antibodies with optimal developability using FcRn‑pH‑HPLC as an optimized FcRn affinity chromatography method. mAbs 15:1.
Read now
Read now
Bo Zhao, Yunlong Zhao, Stephanie Adaniya, Yue Fu, Youmi Moon, Justin Heftel, Shuzhen Chen, Hui Xiao & Ning Li. (2023) Understanding the structure–property relationship of bispecific monoclonal antibodies with Fc site-specific substitutions. mAbs 15:1.
Read now
Read now
Jibriil P Ibrahim, Neville J Butcher, Ashok Kothapalli, Christopher N Subasic, Joanne T Blanchfield, Andrew K. Whittaker, Michael R Whittaker & Lisa M Kaminskas. (2023) Utilization of endogenous albumin trafficking pathways in the lungs has potential to modestly increase the lung interstitial access and absorption of drug delivery systems after inhaled administration. Expert Opinion on Drug Delivery 20:8, pages 1145-1155.
Read now
Read now
Jonathan Barker, Giampiero Girolomoni, Alexander Egeberg, Joao Goncalves, Burkhard Pieper & Taegyun Kang. (2020) Anti-TNF biosimilars in psoriasis: from scientific evidence to real-world experience. Journal of Dermatological Treatment 31:8, pages 794-800.
Read now
Read now
Yue Sun, Alberto Estevez, Tilman Schlothauer & Aaron T. Wecksler. (2020) Antigen physiochemical properties allosterically effect the IgG Fc-region and Fc neonatal receptor affinity. mAbs 12:1.
Read now
Read now
Kip P. Conner, Cinthia V. Pastuskovas, Marcus Soto, Veena A. Thomas, Mylo Wagner & Dan A. Rock. (2020) Preclinical characterization of the ADME properties of a surrogate anti-IL-36R monoclonal antibody antagonist in mouse serum and tissues. mAbs 12:1.
Read now
Read now
Thomas E. Kraft, Wolfgang F. Richter, Thomas Emrich, Alexander Knaupp, Michaela Schuster, Andreas Wolfert & Hubert Kettenberger. (2020) Heparin chromatography as an in vitro predictor for antibody clearance rate through pinocytosis. mAbs 12:1.
Read now
Read now
Romain Ollier, Paul Wassmann, Thierry Monney, Christelle Ries Fecourt, Sunitha Gn, Vinu C A, Daniel Ayoub, Cian Stutz, Girish S Gudi & Stanislas Blein. (2019) Single-step Protein A and Protein G avidity purification methods to support bispecific antibody discovery and development. mAbs 11:8, pages 1464-1478.
Read now
Read now
Brian C. Mackness, Julie A. Jaworski, Ekaterina Boudanova, Anna Park, Delphine Valente, Christine Mauriac, Olivier Pasquier, Thorsten Schmidt, Mostafa Kabiri, Abdullah Kandira, Katarina Radošević & Huawei Qiu. (2019) Antibody Fc engineering for enhanced neonatal Fc receptor binding and prolonged circulation half-life. mAbs 11:7, pages 1276-1288.
Read now
Read now
Adam R. Evans, Michael T. Capaldi, Geetha Goparaju, David Colter, Frank F. Shi, Sarah Aubert, Lian-Chao Li, Jingjie Mo, Michael J. Lewis, Ping Hu, Pedro Alfonso & Promod Mehndiratta. (2019) Using bispecific antibodies in forced degradation studies to analyze the structure–function relationships of symmetrically and asymmetrically modified antibodies. mAbs 11:6, pages 1101-1112.
Read now
Read now
Brian M. Maas & Yanguang Cao. (2018) A minimal physiologically based pharmacokinetic model to investigate FcRn-mediated monoclonal antibody salvage: Effects of K, K, endosome trafficking, and animal species. mAbs 10:8, pages 1322-1331.
Read now
Read now
Deni Hardiansyah & Chee Meng Ng. (2018) Effects of the FcRn developmental pharmacology on the pharmacokinetics of therapeutic monoclonal IgG antibody in pediatric subjects using minimal physiologically-based pharmacokinetic modelling. mAbs 10:7, pages 1144-1156.
Read now
Read now
Nicole M. Piche-Nicholas, Lindsay B. Avery, Amy C. King, Mania Kavosi, Mengmeng Wang, Denise M. O'Hara, Lioudmila Tchistiakova & Madan Katragadda. (2018) Changes in complementarity-determining regions significantly alter IgG binding to the neonatal Fc receptor (FcRn) and pharmacokinetics. mAbs 10:1, pages 81-94.
Read now
Read now
Miroslav Dostalek, Thomayant Prueksaritanont & Robert F. Kelley. (2017) Pharmacokinetic de-risking tools for selection of monoclonal antibody lead candidates. mAbs 9:5, pages 756-766.
Read now
Read now
Claudia A. Castro Jaramillo, Sara Belli, Anne-Christine Cascais, Sherri Dudal, Martin R. Edelmann, Markus Haak, Marie-Elise Brun, Michael B. Otteneder, Mohammed Ullah, Christoph Funk, Franz Schuler & Silke Simon. (2017) Toward in vitro-to-in vivo translation of monoclonal antibody pharmacokinetics: Application of a neonatal Fc receptor-mediated transcytosis assay to understand the interplaying clearance mechanisms. mAbs 9:5, pages 781-791.
Read now
Read now
Xiangdan Wang, Patrick McKay, Liliana T. Yee, George Dutina, Philip E. Hass, Ihsan Nijem, David Allison, Kyra J. Cowan, Kevin Lin, Valerie Quarmby & Jihong Yang. (2017) Impact of SPR biosensor assay configuration on antibody: Neonatal Fc receptor binding data. mAbs 9:2, pages 319-332.
Read now
Read now
Ryan L. Kelly, Yao Yu, Tingwan Sun, Isabelle Caffry, Heather Lynaugh, Michael Brown, Tushar Jain, Yingda Xu & K. Dane Wittrup. (2016) Target-independent variable region mediated effects on antibody clearance can be FcRn independent. mAbs 8:7, pages 1269-1275.
Read now
Read now
Anke Steinmetz, François Vallée, Christian Beil, Christian Lange, Nicolas Baurin, Jochen Beninga, Cécile Capdevila, Carsten Corvey, Alain Dupuy, Paul Ferrari, Alexey Rak, Peter Wonerow, Jochen Kruip, Vincent Mikol & Ercole Rao. (2016) CODV-Ig, a universal bispecific tetravalent and multifunctional immunoglobulin format for medical applications. mAbs 8:5, pages 867-878.
Read now
Read now
Stephen T. Buckley, František Hubálek & Ulrik Lytt Rahbek. (2016) Chemically modified peptides and proteins - critical considerations for oral delivery. Tissue Barriers 4:2.
Read now
Read now
Kathryn Chapman, Akosua Adjei, Paul Baldrick, Antonio da Silva, Karen De Smet, Richard DiCicco, Seung Suh Hong, David Jones, Michael W. Leach, James McBlane, Ian Ragan, Praveen Reddy, Donald I. H. Stewart, Amanda Suitters & Jennifer Sims. (2016) Waiving in vivo studies for monoclonal antibody biosimilar development: National and global challenges. mAbs 8:3, pages 427-435.
Read now
Read now
Minoru Tada, Ken-Ichiro Tatematsu, Akiko Ishii-Watabe, Akira Harazono, Daisuke Takakura, Noritaka Hashii, Hideki Sezutsu & Nana Kawasaki. (2015) Characterization of anti-CD20 monoclonal antibody produced by transgenic silkworms (Bombyx mori). mAbs 7:6, pages 1138-1150.
Read now
Read now
Markus Haberger, Anna-Katharina Heidenreich, Tilman Schlothauer, Michaela Hook, Jana Gassner, Katrin Bomans, Michelle Yegres, Adrian Zwick, Boris Zimmermann, Harald Wegele, Lea Bonnington, Dietmar Reusch & Patrick Bulau. (2015) Functional assessment of antibody oxidation by native mass spectrometry. mAbs 7:5, pages 891-900.
Read now
Read now
Articles from other publishers (99)
Pieter-Jan De Sutter, Elke Gasthuys & An Vermeulen. (2023) Comparison of monoclonal antibody disposition predictions using different physiologically based pharmacokinetic modelling platforms. Journal of Pharmacokinetics and Pharmacodynamics.
Crossref
Crossref
Thoa Thi Kim Nguyen, Khang-Yen Pham & Simmyung Yook. (2023) Engineered therapeutic proteins for sustained-release drug delivery systems. Acta Biomaterialia 171, pages 131-154.
Crossref
Crossref
Michal Pyzik, Lisa K. Kozicky, Amit K. Gandhi & Richard S. Blumberg. (2023) The therapeutic age of the neonatal Fc receptor. Nature Reviews Immunology 23:7, pages 415-432.
Crossref
Crossref
Ayhan Parlar, Busra Gurel, Mehmet Reşit Sönmez & Meral Yüce. (2023) Analytical Investigation of Forced Oxidized Anti-VEGF IgG Molecules: A Focus on the Alterations in Antigen and Receptor Binding Activities. Scientia Pharmaceutica 91:3, pages 31.
Crossref
Crossref
Wilhelmus E. A. de Witte, Lindsay B. Avery, Brian C. Mackness, Tom Van Bogaert, Anna Park & Maria Laura Sargentini-Maier. (2023) Mechanistic incorporation of FcRn binding in plasma and endosomes in a whole body PBPK model for large molecules. Journal of Pharmacokinetics and Pharmacodynamics 50:3, pages 229-241.
Crossref
Crossref
Xizhe Gao, Yi-Hua Sheng, Sijia Yu, Jiadong Li, Raymond Rosa, Simone Girgis, Tiffany Guo, Luigi Brunetti & Leonid Kagan. (2023) Mechanisms of Obesity-Induced Changes in Pharmacokinetics of IgG in Rats. Pharmaceutical Research 40:5, pages 1223-1238.
Crossref
Crossref
Nia Toshkova, Violeta Zhelyazkova, Sune Justesen & Jordan D. Dimitrov. (2023) Conservative pattern of interaction of bat and human IgG antibodies with FcRn. Developmental & Comparative Immunology 139, pages 104579.
Crossref
Crossref
Mikhail Volkov, Maximilian Brinkhaus, Karin A. van Schie, Albert Bondt, Theresa Kissel, Elvera J. van der Kooi, Arthur E. H. Bentlage, Carolien A. M. Koeleman, Steven W. de Taeye, Ninotska I. Derksen, Radboud J. E. M. Dolhain, Ute Braig-Scherer, Tom W. J. Huizinga, Manfred Wuhrer, René E. M. Toes, Gestur Vidarsson & Diane van der Woude. (2023) IgG Fab Glycans Hinder FcRn-Mediated Placental Transport. The Journal of Immunology 210:2, pages 158-167.
Crossref
Crossref
Kenta Haraya & Tatsuhiko Tachibana. (2022) Translational Approach for Predicting Human Pharmacokinetics of Engineered Therapeutic Monoclonal Antibodies with Increased FcRn-Binding Mutations. BioDrugs 37:1, pages 99-108.
Crossref
Crossref
Thaís P. Nascimento, Alexandre Vilhena Silva-Neto, Djane Clarys Baia-da-Silva, Patrícia Carvalho da Silva Balieiro, Antônio Alcirley da Silva Baleiro, Jacqueline Sachett, Lisele Brasileiro, Marco A. Sartim, Flor Ernestina Martinez-Espinosa, Fan Hui Wen, Manuela B. Pucca, Charles J. Gerardo, Vanderson S. Sampaio, Priscila Ferreira de Aquino & Wuelton M. Monteiro. (2022) Pregnancy outcomes after snakebite envenomations: A retrospective cohort in the Brazilian Amazonia. PLOS Neglected Tropical Diseases 16:12, pages e0010963.
Crossref
Crossref
Silvia Baroncelli, Clementina M. Galluzzo, Stefano Orlando, Robert Mphwere, Thom Kavalo, Richard Luhanga, Roberta Amici, Marco Floridia, Mauro Andreotti, Fausto Ciccacci, Maria Cristina Marazzi & Marina Giuliano. (2022) Immunoglobulin G passive transfer from mothers to infants: total IgG, IgG subclasses and specific antipneumococcal IgG in 6-week Malawian infants exposed or unexposed to HIV. BMC Infectious Diseases 22:1.
Crossref
Crossref
Yanqun Xu, Yong He, Sanaz Momben-Abolfath, Devin Vertrees, Xiaohong Li, Malgorzata G. Norton & Evi Budo Struble. (2022) Zika Virus Infection and Antibody Neutralization in FcRn Expressing Placenta and Engineered Cell Lines. Vaccines 10:12, pages 2059.
Crossref
Crossref
Adem Hadjabdelhafid-Parisien, Sebastian Bitsch, Arturo Macarrón Palacios, Lukas Deweid, Harald Kolmar & Joelle N. Pelletier. (2022) Tag-free, specific conjugation of glycosylated IgG1 antibodies using microbial transglutaminase. RSC Advances 12:52, pages 33510-33515.
Crossref
Crossref
Sanghwan Ko, Sora Park, Myung Ho Sohn, Migyeong Jo, Byoung Joon Ko, Jung-Hyun Na, Hojin Yoo, Ae Lee Jeong, Kyungsoo Ha, Ju Rang Woo, Chungsu Lim, Jung Hyu Shin, Dohyun Lee, So-Young Choi & Sang Taek Jung. (2022) An Fc variant with two mutations confers prolonged serum half-life and enhanced effector functions on IgG antibodies. Experimental & Molecular Medicine 54:11, pages 1850-1861.
Crossref
Crossref
Maximilian Brinkhaus, Erwin Pannecoucke, Elvera J. van der Kooi, Arthur E. H. Bentlage, Ninotska I. L. Derksen, Julie Andries, Bianca Balbino, Magdalena Sips, Peter Ulrichts, Peter Verheesen, Hans de Haard, Theo Rispens, Savvas N. Savvides & Gestur Vidarsson. (2022) The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement. Nature Communications 13:1.
Crossref
Crossref
Wenpeng Zhang, Yanan Xiang, Lingchao Wang, Furun Wang, Guanglu Li & Xiaomei Zhuang. (2022) Translational pharmacokinetics of a novel bispecific antibody against Ebola virus (MBS77E) from animal to human by PBPK modeling & simulation. International Journal of Pharmaceutics 626, pages 122160.
Crossref
Crossref
Ana Rita Cruz, Arthur E. H. Bentlage, Robin Blonk, Carla J. C. de Haas, Piet C. Aerts, Lisette M. Scheepmaker, Inge G. Bouwmeester, Anja Lux, Jos A. G. van Strijp, Falk Nimmerjahn, Kok P. M. van Kessel, Gestur Vidarsson & Suzan H. M. Rooijakkers. (2022) Toward Understanding How Staphylococcal Protein A Inhibits IgG-Mediated Phagocytosis. The Journal of Immunology 209:6, pages 1146-1155.
Crossref
Crossref
Sepideh Dolatshahi, Audrey L. Butler, Christian Pou, Ewa Henckel, Anna Karin Bernhardsson, Anna Gustafsson, Kajsa Bohlin, Sally A. Shin, Douglas A. Lauffenburger, Petter Brodin & Galit Alter. (2022) Selective transfer of maternal antibodies in preterm and fullterm children. Scientific Reports 12:1.
Crossref
Crossref
Bo Wang, Jun Lin, Matthew R Hoag, Meredith Wright, Mingjun Ma, Wenyan Cai, Sachith Gallolu Kankanamalage & Yue Liu. (2022) A novel IgG Fc by computer-aided design enhances heavy-chain heterodimerization in bi- or trispecific antibodies. Antibody Therapeutics 5:3, pages 216-225.
Crossref
Crossref
Busra Gurel, Melike Berksoz, Eda Capkin, Ayhan Parlar, Meltem Corbacioglu Pala, Aylin Ozkan, Yılmaz Capan, Duygu Emine Daglikoca & Meral Yuce. (2022) Structural and Functional Analysis of CEX Fractions Collected from a Novel Avastin® Biosimilar Candidate and Its Innovator: A Comparative Study. Pharmaceutics 14:8, pages 1571.
Crossref
Crossref
Nidhi Nath, Becky Godat, Rod Flemming & Marjeta Urh. (2022) A homogeneous bioluminescent immunoassay for parallel characterization of binding between a panel of antibodies and a family of Fcγ receptors. Scientific Reports 12:1.
Crossref
Crossref
Zheng Yang, Surendran Rajendran, Vanessa Spires, Brian Poirson, Murali Gururajan, Zheng Lin, Jaren Arbanas, Stanley Krystek, James Loy, Yuan Cheng, Stephen Carl, Samantha Pace, Yun Wang, John Mehl, Shihua Xu, Krishna Vasudevan, Miranda Broz, Lois Lehman-McKeeman, Paul Morin & Robert F. Graziano. (2022) Target-Mediated Drug Disposition Affects the Pharmacokinetics of Interleukin-10 Fragment Crystallizable Fusion Proteins at Pharmacologically Active Doses. Drug Metabolism and Disposition 50:7, pages 898-908.
Crossref
Crossref
Büşra Gürel, Eda Çapkın, Ayhan Parlar, Aylin Özkan, Meltem Çorbacıoğlu, Duygu Emine Dağlikoca & Meral Yüce. (2022) Optimized Methods for Analytical and Functional Comparison of Biosimilar mAb Drugs: A Case Study for Avastin, Mvasi, and Zirabev. Scientia Pharmaceutica 90:2, pages 36.
Crossref
Crossref
Kenta Haraya, Haruka Tsutsui, Yasunori Komori & Tatsuhiko Tachibana. (2022) Recent Advances in Translational Pharmacokinetics and Pharmacodynamics Prediction of Therapeutic Antibodies Using Modeling and Simulation. Pharmaceuticals 15:5, pages 508.
Crossref
Crossref
Anna Zakrzewicz, Celina Würth, Benedikt Beckert, Simon Feldhoff, Katrien Vanderheyden, Stian Foss, Jan Terje Andersen, Hans de Haard, Peter Verheesen, Vladimir Bobkov & Ritva Tikkanen. (2022) Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus?. Cells 11:6, pages 942.
Crossref
Crossref
Deni Hardiansyah & Chee Meng Ng. (2022) Minimal Physiologically-based Pharmacokinetic Model to Investigate the Effect of Charge on the Pharmacokinetics of Humanized anti-HCV-E2 IgG Antibodies in Sprague–Dawley Rats. Pharmaceutical Research 39:3, pages 481-496.
Crossref
Crossref
Algirdas Grevys, Rahel Frick, Simone Mester, Karine Flem-Karlsen, Jeannette Nilsen, Stian Foss, Kine Marita Knudsen Sand, Thomas Emrich, Jens Andre Alexander Fischer, Victor Greiff, Inger Sandlie, Tilman Schlothauer & Jan Terje Andersen. (2022) Antibody variable sequences have a pronounced effect on cellular transport and plasma half-life. iScience 25:2, pages 103746.
Crossref
Crossref
Maximilian Brinkhaus, Elvera J. van der Kooi, Arthur E. H. Bentlage, Pleuni Ooijevaar-de Heer, Ninotska I. L. Derksen, Theo Rispens & Gestur Vidarsson. (2022) Human IgE does not bind to human FcRn. Scientific Reports 12:1.
Crossref
Crossref
莹莹 陈. (2022) Method Development Strategies for Analysis of Binding Activity between Proteins Based on Surface Plasmon Resonance Technology. Advances in Analytical Chemistry 12:03, pages 178-184.
Crossref
Crossref
Rocio Lledo‐Garcia, Kate Dixon, Anthony Shock & Ruth Oliver. (2021) Pharmacokinetic‐pharmacodynamic modelling of the anti‐FcRn monoclonal antibody rozanolixizumab: Translation from preclinical stages to the clinic. CPT: Pharmacometrics & Systems Pharmacology 11:1, pages 116-128.
Crossref
Crossref
Xujiao Ren, Ping Qian, Shudan Liu, Huanchun Chen & Xiangmin Li. (2021) Fc-Mediated E2-Dimer Subunit Vaccines of Atypical Porcine Pestivirus Induce Efficient Humoral and Cellular Immune Responses in Piglets. Viruses 13:12, pages 2443.
Crossref
Crossref
Michael P. Citron, Jessica McAnulty, Cheryl Callahan, Walter Knapp, Jane Fontenot, Pablo Morales, Jessica A. Flynn, Cameron M. Douglas & Amy S. Espeseth. (2021) Transplacental Antibody Transfer of Respiratory Syncytial Virus Specific IgG in Non-Human Primate Mother-Infant Pairs. Pathogens 10:11, pages 1441.
Crossref
Crossref
Huifang Li, Feng Xu, Chang Liu, Ang Cai, Joel A. Dain, Dongli Li, Navindra P. Seeram, Bongsup P. Cho & Hang Ma. (2021) Inhibitory Effects and Surface Plasmon Resonance-Based Binding Affinities of Dietary Hydrolyzable Tannins and Their Gut Microbial Metabolites on SARS-CoV-2 Main Protease. Journal of Agricultural and Food Chemistry 69:41, pages 12197-12208.
Crossref
Crossref
Arianne Lovey, Mila Krel, Allen Borchardt, Thomas Brady, Jason N. Cole, Quyen-Quyen Do, Joanne Fortier, Grayson Hough, Wanlong Jiang, Alain Noncovich, Les Tari, Qiping Zhao, James M. Balkovec, Yanan Zhao & David S. Perlin. (2021) Development of Novel Immunoprophylactic Agents against Multidrug-Resistant Gram-Negative Bacterial Infections. Antimicrobial Agents and Chemotherapy 65:11.
Crossref
Crossref
Nidhi Nath, Becky Godat, Rod Flemming & Marjeta Urh. (2021) Deciphering the Interaction between Neonatal Fc Receptor and Antibodies Using a Homogeneous Bioluminescent Immunoassay. The Journal of Immunology 207:4, pages 1211-1221.
Crossref
Crossref
Rocío Ramos-Membrive, Álvaro Erhard, Inés Luis de Redín, Gemma Quincoces, María Collantes, Margarita Ecay, Juan Manuel Irache & Iván Peñuelas. (2021) In vivo SPECT-CT imaging and characterization of technetium-99m-labeled bevacizumab-loaded human serum albumin pegylated nanoparticles. Journal of Drug Delivery Science and Technology 64, pages 101809.
Crossref
Crossref
Valegh Faid, Yann Leblanc, Marie Berger, Alexander Seifert, Nicolas Bihoreau & Guillaume Chevreux. (2021) C-terminal lysine clipping of IgG1: impact on binding to human FcγRIIIa and neonatal Fc receptors. European Journal of Pharmaceutical Sciences 159, pages 105730.
Crossref
Crossref
Toshihiko Tashima. (2021) Delivery of Orally Administered Digestible Antibodies Using Nanoparticles. International Journal of Molecular Sciences 22:7, pages 3349.
Crossref
Crossref
Timothy Qi & Yanguang Cao. (2021) In Translation: FcRn across the Therapeutic Spectrum. International Journal of Molecular Sciences 22:6, pages 3048.
Crossref
Crossref
Selena Alonso, Marta Vidal, Gemma Ruiz-Olalla, Raquel González, M. Nelia Manaca, Chenjerai Jairoce, Miquel Vázquez-Santiago, Reyes Balcells, Anifa Vala, María Rupérez, Pau Cisteró, Laura Fuente-Soro, Marta Cova, Evelina Angov, Arsenio Nhacolo, Esperança Sevene, John J. Aponte, Eusebio Macete, Ruth Aguilar, Alfredo Mayor, Clara Menéndez, Carlota Dobaño & Gemma Moncunill. (2021) Reduced Placental Transfer of Antibodies Against a Wide Range of Microbial and Vaccine Antigens in HIV-Infected Women in Mozambique. Frontiers in Immunology 12.
Crossref
Crossref
Sanghwan Ko, Migyeong Jo & Sang Taek Jung. (2021) Recent Achievements and Challenges in Prolonging the Serum Half-Lives of Therapeutic IgG Antibodies Through Fc Engineering. BioDrugs 35:2, pages 147-157.
Crossref
Crossref
Yanqun Xu, Yong He, Sanaz Momben-Abolfath, Nancy Eller, Malgorzata Norton, Pei Zhang, Dorothy Scott & Evi Budo Struble. (2021) Entry and Disposition of Zika Virus Immune Complexes in a Tissue Culture Model of the Maternal-Fetal Interface. Vaccines 9:2, pages 145.
Crossref
Crossref
Wei Lv & Julie A. Champion. (2021) Demonstration of intracellular trafficking, cytosolic bioavailability, and target manipulation of an antibody delivery platform. Nanomedicine: Nanotechnology, Biology and Medicine 32, pages 102315.
Crossref
Crossref
Júlia Anna Láng, Zsófia Cselovszkiné Balogh, Mónika Fizilné Nyitrai, Cintia Juhász, Anna Katalin Baráné Gilicze, Attila Iliás, Zsolt Zólyomi, Csaba Bodor & Erzsébet Rábai. (2020) In vitro functional characterization of biosimilar therapeutic antibodies. Drug Discovery Today: Technologies 37, pages 41-50.
Crossref
Crossref
Adriana Bajardi-Taccioli, Carl Co, Christine Bond, Allyson Masci, Tim Brantley, Chongfeng Xu, Svetlana Bergelson & Marina Feschenko. (2020) Biolayer Interferometry-based FcγRIIa binding assay for a therapeutic antibody with strong effector function. Analytical Biochemistry 611, pages 113842.
Crossref
Crossref
Esther Kuilamu, Christopher Subasic, Gary J Cowin, Fiona Simpson, Rodney F Minchin & Lisa M Kaminskas. (2020) Cetuximab Exhibits Sex Differences in Lymphatic Exposure after Intravenous Administration in Rats in the Absence of Differences in Plasma Exposure. Pharmaceutical Research 37:11.
Crossref
Crossref
Malin Bern, Jeannette Nilsen, Mattia Ferrarese, Kine M. K. Sand, Torleif T. GjølbergHeidrun E. Lode, Robert J. DavidsonRodney M. CamireEspen S. BækkevoldStian Foss, Algirdas Grevys, Bjørn Dalhus, John WilsonLene S. Høydahl, Gregory J. Christianson, Derry C. Roopenian, Tilman SchlothauerTerje E. Michaelsen, Morten C. Moe, Silvia Lombardi, Mirko Pinotti, Inger SandlieAlessio Branchini & Jan Terje Andersen. (2020) An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologics. Science Translational Medicine 12:565.
Crossref
Crossref
Toby Clements, Thomas F. Rice, George Vamvakas, Sara Barnett, Megan Barnes, Beverly Donaldson, Christine E. Jones, Beate Kampmann & Beth Holder. (2020) Update on Transplacental Transfer of IgG Subclasses: Impact of Maternal and Fetal Factors. Frontiers in Immunology 11.
Crossref
Crossref
Kip P. Conner, Siva Charan Devanaboyina, Veena A. Thomas & Dan A. Rock. (2020) The biodistribution of therapeutic proteins: Mechanism, implications for pharmacokinetics, and methods of evaluation. Pharmacology & Therapeutics 212, pages 107574.
Crossref
Crossref
Anja Saso & Beate Kampmann. (2020) Maternal Immunization: Nature Meets Nurture. Frontiers in Microbiology 11.
Crossref
Crossref
Cian Stutz & Stanislas Blein. (2020) A single mutation increases heavy-chain heterodimer assembly of bispecific antibodies by inducing structural disorder in one homodimer species. Journal of Biological Chemistry 295:28, pages 9392-9408.
Crossref
Crossref
Diana Cadena Castaneda, Guillaume Brachet, Caroline Goupille, Lobna Ouldamer & Valérie Gouilleux‐Gruart. (2020) The neonatal Fc receptor in cancer FcRn in cancer. Cancer Medicine 9:13, pages 4736-4742.
Crossref
Crossref
Fabian Soltermann, Eric D. B. Foley, Veronica Pagnoni, Martin Galpin, Justin L. P. Benesch, Philipp Kukura & Weston B. Struwe. (2020) Quantifying Protein–Protein Interactions by Molecular Counting with Mass Photometry. Angewandte Chemie International Edition 59:27, pages 10774-10779.
Crossref
Crossref
Fabian Soltermann, Eric D. B. Foley, Veronica Pagnoni, Martin Galpin, Justin L. P. Benesch, Philipp Kukura & Weston B. Struwe. (2020) Quantifying Protein–Protein Interactions by Molecular Counting with Mass Photometry. Angewandte Chemie 132:27, pages 10866-10871.
Crossref
Crossref
Robert J Oldham, C Ian Mockridge, Sonya James, Patrick J Duriez, H T Claude Chan, Kerry L Cox, Vicentiu A Pitic, Martin J Glennie & Mark S Cragg. (2020) FcγRII (CD32) modulates antibody clearance in NOD SCID mice leading to impaired antibody-mediated tumor cell deletion. Journal for ImmunoTherapy of Cancer 8:1, pages e000619.
Crossref
Crossref
Annalisa L. Post, Shuk Hang Li, Madison Berry, Hannah Itell, David R. Martinez, Guanhua Xie, Sallie R. Permar, Geeta K. Swamy & Genevieve G. Fouda. (2020) Efficiency of placental transfer of vaccine-elicited antibodies relative to prenatal Tdap vaccination status. Vaccine 38:31, pages 4869-4876.
Crossref
Crossref
Dennis R. Goulet, Adam Zwolak, James A. Williams, Mark L. Chiu & William M. Atkins. (2019) Design and characterization of novel dual Fc antibody with enhanced avidity for Fc receptors. Proteins: Structure, Function, and Bioinformatics 88:5, pages 689-697.
Crossref
Crossref
Szymon Stelter, Mathew J. Paul, Audrey Y.‐H. Teh, Melanie Grandits, Friedrich Altmann, Jessica Vanier, Muriel Bardor, Alexandra Castilho, Rachel Louise Allen & Julian K‐C. Ma. (2019)
Engineering the interactions between a plant‐produced
HIV
antibody and human Fc receptors
. Plant Biotechnology Journal 18:2, pages 402-414.
Crossref
Crossref
Chang-Han Lee, Tae Hyun Kang, Ophélie Godon, Makiko Watanabe, George Delidakis, Caitlin M. Gillis, Delphine Sterlin, David Hardy, Michel Cogné, Lynn E. Macdonald, Andrew J. Murphy, Naxin Tu, Jiwon Lee, Jonathan R. McDaniel, Emily Makowski, Peter M. Tessier, Aaron S. Meyer, Pierre Bruhns & George Georgiou. (2019) An engineered human Fc domain that behaves like a pH-toggle switch for ultra-long circulation persistence. Nature Communications 10:1.
Crossref
Crossref
Shigeo Hirasawa, Yoshiro Kitahara, Yoriko Okamatsu, Tomohiro Fujii, Akira Nakayama, Satoko Ueno, Chiori Ijichi, Fumie Futaki, Kunio Nakata & Masumi Taki. (2019) Facile and Efficient Chemoenzymatic Semisynthesis of Fc-Fusion Compounds for Half-Life Extension of Pharmaceutical Components. Bioconjugate Chemistry 30:9, pages 2323-2331.
Crossref
Crossref
Godakova, Noskov, Vinogradova, Ugriumova, Solovyev, Esmagambetov, Tukhvatulin, Logunov, Naroditsky, Shcheblyakov & Gintsburg. (2019) Camelid VHHs Fused to Human Fc Fragments Provide Long Term Protection Against Botulinum Neurotoxin A in Mice. Toxins 11:8, pages 464.
Crossref
Crossref
Prathap Kumar Mahalingaiah, Rita Ciurlionis, Kenneth R. Durbin, Ronnie L. Yeager, Binu K. Philip, Bhupinder Bawa, Srinivasa R. Mantena, Brian P. Enright, Michael J. Liguori & Terry R. Van Vleet. (2019) Potential mechanisms of target-independent uptake and toxicity of antibody-drug conjugates. Pharmacology & Therapeutics 200, pages 110-125.
Crossref
Crossref
Armin Sepp, Guy Meno-Tetang, Andrew Weber, Andrew Sanderson, Oliver Schon & Alienor Berges. (2019) Computer-assembled cross-species/cross-modalities two-pore physiologically based pharmacokinetic model for biologics in mice and rats. Journal of Pharmacokinetics and Pharmacodynamics 46:4, pages 339-359.
Crossref
Crossref
Michal Pyzik, Kine M. K. Sand, Jonathan J. Hubbard, Jan Terje Andersen, Inger Sandlie & Richard S. Blumberg. (2019) The Neonatal Fc Receptor (FcRn): A Misnomer?. Frontiers in Immunology 10.
Crossref
Crossref
David R. Martinez, Youyi Fong, Shuk Hang Li, Fang Yang, Madeleine F. Jennewein, Joshua A. Weiner, Erin A. Harrell, Jesse F. Mangold, Ria Goswami, George R. SeageIIIIII, Galit Alter, Margaret E. Ackerman, Xinxia Peng, Genevieve G. Fouda & Sallie R. Permar. (2019) Fc Characteristics Mediate Selective Placental Transfer of IgG in HIV-Infected Women. Cell 178:1, pages 190-201.e11.
Crossref
Crossref
Alanod D. AlQahtani, David O’Connor, Alexander Domling & Sayed K. Goda. (2019) Strategies for the production of long-acting therapeutics and efficient drug delivery for cancer treatment. Biomedicine & Pharmacotherapy 113, pages 108750.
Crossref
Crossref
Honghui Zhou & Diane R. MouldDeni Hardiansyah & Chee M. Ng. 2019. Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune‐Mediated Inflammatory Diseases. Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune‐Mediated Inflammatory Diseases
285
314
.
Kenta Haraya, Tatsuhiko Tachibana & Tomoyuki Igawa. (2019) Improvement of pharmacokinetic properties of therapeutic antibodies by antibody engineering. Drug Metabolism and Pharmacokinetics 34:1, pages 25-41.
Crossref
Crossref
Paul A. Hampel, Ralf Strasser, Frank Fischer & Ulrich Rant. (2018) Assembly and Characterization of a Slingshot DNA Nanostructure for the Analysis of Bivalent and Bispecific Analytes with Biosensors. Langmuir 34:49, pages 14796-14801.
Crossref
Crossref
Dennis R. Goulet, Michael J. Watson, Susan H. Tam, Adam Zwolak, Mark L. Chiu, William M. Atkins & Abhinav Nath. (2018) Toward a Combinatorial Approach for the Prediction of IgG Half-Life and Clearance. Drug Metabolism and Disposition 46:12, pages 1900-1907.
Crossref
Crossref
Deni Hardiansyah & Chee Meng Ng. (2018) Minimal physiologically-based pharmacokinetic model to investigate the effect of pH dependent FcRn affinity and the endothelial endocytosis on the pharmacokinetics of anti-VEGF humanized IgG1 antibody in cynomolgus monkey. European Journal of Pharmaceutical Sciences 125, pages 130-141.
Crossref
Crossref
Matthew G. Zimmerman, Kendra M. Quicke, Justin T. O'Neal, Nitin Arora, Deepa Machiah, Lalita Priyamvada, Robert C. Kauffman, Emery Register, Oluwaseyi Adekunle, Dominika Swieboda, Erica L. Johnson, Sarah Cordes, Lisa Haddad, Rana Chakraborty, Carolyn B. Coyne, Jens Wrammert & Mehul S. Suthar. (2018) Cross-Reactive Dengue Virus Antibodies Augment Zika Virus Infection of Human Placental Macrophages. Cell Host & Microbe 24:5, pages 731-742.e6.
Crossref
Crossref
Li Zhou, Jun Zhang, Enrico DiGiammarino, Amol Kavishwar, Bo Yan, Chris Chumsae, Peter M. Ihnat, David Powers, John Harlan & William Blaine Stine. (2018) PULSE SPR: A High Throughput Method to Evaluate the Domain Stability of Antibodies. Analytical Chemistry 90:20, pages 12221-12229.
Crossref
Crossref
Peter Ulrichts, Antonio Guglietta, Torsten Dreier, Tonke van Bragt, Valérie Hanssens, Erik Hofman, Bernhardt Vankerckhoven, Peter Verheesen, Nicolas Ongenae, Valentina Lykhopiy, F. Javier Enriquez, JunHaeng Cho, Raimund J. Ober, E. Sally Ward, Hans de Haard & Nicolas Leupin. (2018) Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans. Journal of Clinical
Investigation 128:10, pages 4372-4386.
Crossref
Crossref
Simone Mader, Lior Brimberg, John N. Soltys, Jeffrey L. Bennett & Betty Diamond. (2018) Mutations of Recombinant Aquaporin-4 Antibody in the Fc Domain Can Impair Complement-Dependent Cellular Cytotoxicity and Transplacental Transport. Frontiers in Immunology 9.
Crossref
Crossref
Dongfen Yuan, Frederik Rode & Yanguang Cao. (2018) A Minimal Physiologically Based Pharmacokinetic Model with a Nested Endosome Compartment for Novel Engineered Antibodies. The AAPS Journal 20:3.
Crossref
Crossref
Ingrid Schmid, Lea Bonnington, Monika Gerl, Katrin Bomans, Anna Louisa Thaller, Katharina Wagner, Tilman Schlothauer, Roberto Falkenstein, Boris Zimmermann, Jürgen Kopitz, Max Hasmann, Frieder Bauss, Markus Haberger, Dietmar Reusch & Patrick Bulau. (2018) Assessment of susceptible chemical modification sites of trastuzumab and endogenous human immunoglobulins at physiological conditions. Communications Biology 1:1.
Crossref
Crossref
Florian Cymer, Hermann Beck, Adelheid Rohde & Dietmar Reusch. (2018) Therapeutic monoclonal antibody N-glycosylation – Structure, function and therapeutic potential. Biologicals 52, pages 1-11.
Crossref
Crossref
Deni Hardiansyah & Chee Meng Ng. (2018) Two-Pore Minimum Physiologically-based Pharmacokinetic Model to Describe the Disposition of Therapeutic Monoclonal IgG Antibody in Humans. Pharmaceutical Research 35:3.
Crossref
Crossref
Genevieve G. Fouda, David R. Martinez, Geeta K. Swamy & Sallie R. Permar. (2018) The Impact of IgG Transplacental Transfer on Early Life Immunity. ImmunoHorizons 2:1, pages 14-25.
Crossref
Crossref
Christopher R. Wilcox, Beth Holder & Christine E. Jones. (2017) Factors Affecting the FcRn-Mediated Transplacental Transfer of Antibodies and Implications for Vaccination in Pregnancy. Frontiers in Immunology 8.
Crossref
Crossref
Jon A. Kenniston, Brandy M. Taylor, Gregory P. Conley, Janja Cosic, Kris J. Kopacz, Allison P. Lindberg, Stephen R. Comeau, Kateri Atkins, Jameson Bullen, Christopher TenHoor, Burt A. Adelman, Daniel J. Sexton, Thomas E. Edwards & Andrew E. Nixon. (2017) Structural basis for pH-insensitive inhibition of immunoglobulin G recycling by an anti-neonatal Fc receptor antibody. Journal of Biological Chemistry 292:42, pages 17449-17460.
Crossref
Crossref
Bence Szikora, László Hiripi, Balázs Bender, Imre Kacskovics & Attila Iliás. (2017) Characterization of the interactions of rabbit neonatal Fc receptor (FcRn) with rabbit and human IgG isotypes. PLOS ONE 12:9, pages e0185662.
Crossref
Crossref
Florian Cymer, Tilman Schlothauer, Alexander Knaupp & Hermann Beck. (2017) Evaluation of an FcRn affinity chromatographic method for IgG1-type antibodies and evaluation of IgG variants. Bioanalysis 9:17, pages 1305-1317.
Crossref
Crossref
Saskia Fuhrmann, Charlotte Kloft & Wilhelm Huisinga. (2017) Impact of altered endogenous IgG on unspecific mAb clearance. Journal of Pharmacokinetics and Pharmacodynamics 44:4, pages 351-374.
Crossref
Crossref
Darko Skegro, Cian Stutz, Romain Ollier, Emelie Svensson, Paul Wassmann, Florence Bourquin, Thierry Monney, Sunitha Gn & Stanislas Blein. (2017) Immunoglobulin domain interface exchange as a platform technology for the generation of Fc heterodimers and bispecific antibodies. Journal of Biological Chemistry 292:23, pages 9745-9759.
Crossref
Crossref
Sari Latvala, Bjoern Jacobsen, Michael B. Otteneder, Annika Herrmann & Sven Kronenberg. (2017) Distribution of FcRn Across Species and Tissues. Journal of Histochemistry & Cytochemistry 65:6, pages 321-333.
Crossref
Crossref
Pernille Foged Jensen, Angela Schoch, Vincent Larraillet, Maximiliane Hilger, Tilman Schlothauer, Thomas Emrich & Kasper Dyrberg Rand. (2017) A Two-pronged Binding Mechanism of IgG to the Neonatal Fc Receptor Controls Complex Stability and IgG Serum Half-life. Molecular & Cellular Proteomics 16:3, pages 451-456.
Crossref
Crossref
Li Zhou, Hsuan-Yao Wang, Shanshan Tong, Curtis T. Okamoto, Wei-Chiang Shen & Jennica L. Zaro. (2017) Single chain Fc-dimer-human growth hormone fusion protein for improved drug delivery. Biomaterials 117, pages 24-31.
Crossref
Crossref
Priyasma Bhoumik, Alberto Del Rio-Espinola, Florian Hahne, Jonathan Moggs & Olivier Grenet. (2016) Translational Safety Genetics. Toxicologic Pathology 45:1, pages 119-126.
Crossref
Crossref
Hiroshi Imamura & Shinya Honda. (2017) Calibration-free concentration analysis for an analyte prone to self-association. Analytical Biochemistry 516, pages 61-64.
Crossref
Crossref
Robert Karlsson. (2016) Biosensor binding data and its applicability to the determination of active concentration. Biophysical Reviews 8:4, pages 347-358.
Crossref
Crossref
Mazin Derzi, Theodore R. Johnson, Ahmed M. Shoieb, Hugh D. Conlon, Penny Sharpe, Andrew Saati, Sarah Koob, Michael W. Bolt, Leslie G. Lorello, Jim McNally, Carol F. Kirchhoff, Teresa A. Smolarek & Michael W. Leach. (2016) Nonclinical Evaluation of PF-06438179: A Potential Biosimilar to Remicade® (Infliximab). Advances in Therapy 33:11, pages 1964-1982.
Crossref
Crossref
João Pedro Martins, Patrick J. Kennedy, Hélder A. Santos, Cristina Barrias & Bruno Sarmento. (2016) A comprehensive review of the neonatal Fc receptor and its application in drug delivery. Pharmacology & Therapeutics 161, pages 22-39.
Crossref
Crossref
Yangsheng Qiu, Wei Lv, Min Xu & Yuhong Xu. (2016) Single chain antibody fragments with pH dependent binding to FcRn enabled prolonged circulation of therapeutic peptide in vivo. Journal of Controlled Release 229, pages 37-47.
Crossref
Crossref
Guillaume Brachet, Renaud Respaud, Christophe Arnoult, Corinne Henriquet, Christine Dhommée, Marie-Claude Viaud-Massuard, Nathalie Heuze-Vourc’h, Nicolas Joubert, Martine Pugnière & Valérie Gouilleux-Gruart. (2016)
Increment in Drug Loading on an Antibody–Drug Conjugate Increases Its Binding to the Human Neonatal Fc Receptor
in Vitro
. Molecular Pharmaceutics 13:4, pages 1405-1412.
Crossref
Crossref
David Ternant, Christophe Arnoult, Martine Pugnière, Christine Dhommée, Daniel Drocourt, Eric Perouzel, Christophe Passot, Nadine Baroukh, Denis Mulleman, Gérard Tiraby, Hervé Watier, Gilles Paintaud & Valérie Gouilleux-Gruart. (2016) IgG1 Allotypes Influence the Pharmacokinetics of Therapeutic Monoclonal Antibodies through FcRn Binding. The Journal of Immunology 196:2, pages 607-613.
Crossref
Crossref
Adriana Bajardi-Taccioli, Andrew Blum, Chongfeng Xu, Zoran Sosic, Svetlana Bergelson & Marina Feschenko. (2015) Effect of protein aggregates on characterization of FcRn binding of Fc-fusion therapeutics. Molecular Immunology 67:2, pages 616-624.
Crossref
Crossref
James Z. Hui, Shereen Tamsen, Yang Song & Andrew Tsourkas. (2015) LASIC: Light Activated Site-Specific Conjugation of Native IgGs. Bioconjugate Chemistry 26:8, pages 1456-1460.
Crossref
Crossref